Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylation-Reference-Cited by-同舟云学术

Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylation

Published:2001-11 Issue:12 Volume:1 Page:2151-2162
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Vogen Shawn M,Paczkowski Natalii J,Kirnarsky Leonid,Short Anna,Whitmore Jacqueline B,Sherman Simon A,Taylor Stephen M,Sanderson Sam D

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference21 articles.

1. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung;Haviland;J. Immunol.,1995

2. Complement fragment C5a and immunoregulation;Morgan,1993

3. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity;Finch;J. Med. Chem.,1997

4. Determination of structural elements related to the biological activities of a potent decapeptide agonist of human C5a anaphylatoxin;Vogen;J. Pept. Res.,1999

5. Conformationally biased agonist peptides of human C5a mediate changes in vascular permeability;Kawatsu;J. Pharmacol. Exp. Ther.,1996

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors;Cell;2023-10

2. Structural insights into agonist-binding and activation of the human complement C3a receptor;2023-02-09

3. Development of Macrocyclic PRMT5–Adaptor Protein Interaction Inhibitors;Journal of Medicinal Chemistry;2022-11-15

4. Pharmacological activation of the C5a receptor leads to stimulation of the β-adrenergic receptor and alleviates cognitive impairment in a murine model of familial Alzheimer’s disease;Frontiers in Immunology;2022-08-26

5. Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity;Journal of Medicinal Chemistry;2021-11-11